Market Currents
Abbott Labs spin-off AbbVie (ABBV) forecasts 2013 earnings in line with consensus, predicting...
-
Wednesday, January 30, 8:42 AM ETAbbott Labs spin-off AbbVie (ABBV) forecasts 2013 earnings in line with consensus, predicting adjusted EPS of $3.03-$3.13 vs estimates of $3.08. AbbVie expects its growth to be driven by new treatments for illnesses that have a high unmet need.
Other date
Latest Earnings Articles
